Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLPHENIDATE EXTENDED RELEASE for Attention deficit/hyperactivity disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where METHYLPHENIDATE EXTENDED RELEASE was used for Attention deficit/hyperactivity disorder.

Most Reported Side Effects for METHYLPHENIDATE EXTENDED RELEASE

Side Effect Reports % Deaths Hosp.
Drug effect decreased 17 53.1% 0 0
Drug ineffective 11 34.4% 0 0
Drug effect increased 8 25.0% 0 0
Feeling abnormal 6 18.8% 0 0

Other Indications for METHYLPHENIDATE EXTENDED RELEASE

Product used for unknown indication (15)

Other Drugs Used for Attention deficit/hyperactivity disorder

METHYLPHENIDATE (9,093) RISPERIDONE (6,071) LISDEXAMFETAMINE DIMESYLATE (3,793) ATOMOXETINE (3,703) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (3,164) DAYTRANA (1,139) GUANFACINE (896) AMPHETAMINE\DEXTROAMPHETAMINE (407) DEXMETHYLPHENIDATE (378) ARIPIPRAZOLE (372)

Related Pages

METHYLPHENIDATE EXTENDED RELEASE Full Profile All Attention deficit/hyperactivity disorder Drugs METHYLPHENIDATE EXTENDED RELEASE Demographics METHYLPHENIDATE EXTENDED RELEASE Timeline